CTLA-4 is an inhibitory co-receptor constitutively present on Tregs, which plays an important role in regulating CD4+ T cell function, and in HCC, as in other cancer types, it inhibits T cell proliferation through the recognition and differentiation of tumor-associated antigens [156]. Here, CD4 is linked to hepatocellular carcinoma.